Cargando…
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is characterised by the progressive deposition of excessive extracellular matrix proteins within the lung parenchyma and represents the most rapidly progressive and fatal of all fibrotic conditions. Current anti-fibrotic drugs approved for the treatment of IPF fai...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488186/ https://www.ncbi.nlm.nih.gov/pubmed/33060168 http://dx.doi.org/10.1183/16000617.0269-2020 |